Dan Handley, M.S., Ph.D.
Dr. Handley serves as the Chief Scientific Officer of the Clinical and Translational Genome Research Institute. He also holds a courtesy faculty appointment in the Department of Biological Sciences at Florida Gulf Coast University. His areas of specialty include drug-gene interactions (pharmacogenomics), microbiome research and metabolomics, DNA and RNA sequencing, computational systems biology, and machine learning. He previously served as Chief Scientific Officer of Life-SEQ, LLC, a clinical genomic sequencing consulting and services company, as Chief Scientific Officer for Advanced Healthcare Technology Solutions, Inc., as a senior researcher at the Procter & Gamble Co., a senior administrative analyst and laboratory manager at the UCLA School of Medicine, and as a founding technologist for the National Genetics Institute, in Los Angeles, California. He holds a B.A. in Biophysics from Johns Hopkins University, an M.S. in Logic and Computation from Carnegie Mellon University, a Ph.D. in Human Genetics from the University of Pittsburgh, and did his post-doctoral training at Magee-Womens Research Institute in advanced genomic technologies applied to fetal and maternal health.
Bryan M. Rogoff, OD, MBA, CPHM
Bryan M. Rogoff, OD, MBA, CPHM has a unique background in areas of holistic eye care, business management and healthcare reform. His experience spans both the corporate, and private sectors and he continues to specialize in clinical management and operations, market trends, industry analysis, healthcare strategy, and strategic partnerships. Currently, he serves as a consultant for for the FDA as well as other industry partners, Immediate Past-President & Education Chairperson for the Maryland Optometric Association, reviewer for the Council on Optometric Practitioner Education and is the Founder of Eye-Exec Consulting, LLC. Dr. Rogoff received his Bachelors of Science from Stony Brook University, Doctor of Optometry from Nova Southeastern University, and Masters of Business Administration concentrating in Accounting and Taxation from The George Washington University. To understand the complexity of healthcare system, he completed a certification in 2013; CPHM – Certified Professional in Healthcare Management.
Christie Wilcox, Ph.D.
Dr. Wilcox is a scientist and writer based in the greater Seattle area. Her first popular science book, Venomous, was listed as one of the best science books of the year by Smithsonian Magazine and Amazon. Her areas of specialty include toxinology, cell and molecular biology, genetics, ecology, and marine biology. She holds a B.A. with Honors in Marine Science (minor in Chemistry) from Eckerd College, and a Ph.D. in Cell and Molecular Biology with a specialization in Ecology, Evolution and Conservation Biology from the University of Hawaii at Manoa. She did her post-doctoral training in the Pacific Cnidaria Research Library at the University of Hawaii at Manoa where she largely focused on evidence-based sting management.
Sally Rodríguez is a licensed, board-certified genetic counselor who specializes in the area of reproductive genetics. She received her Bachelor’s degree in Molecular Biology from Princeton University in 2009 and her Master’s degree in Genetic Counseling from The Johns Hopkins University Bloomberg School of Public Health in 2013. Shortly after completing her studies, Sally joined Recombine (now CooperGenomics), a start-up genetic testing laboratory specializing in reproductive genetics, and remained with the company for over 4 years, during which she served as Associate Genetic Counselor, Manager of Clinical Affairs, Product Manager, Director of Reproductive Genetics, and finally Global Product Director of Carrier Screening & NIPT after the company’s acquisition by CooperSurgical. Sally is an active member of key professional societies, including the National Society of Genetic Counselors (NSGC) and the American Society for Reproductive Medicine (ASRM). She has given numerous presentations at professional meetings on a variety of topics, including the genetics of recurrent pregnancy loss, expanded carrier screening in the general patient population and gamete donors, and the utility of genetic testing in the fertility setting. Sally has also co-authored numerous abstracts and publications within the field on a variety of topics, including carrier screening, genetic ancestry, genetic telecounseling, the patient experience, and genetic health literacy.
Elizabeth Leight, Ph.D.
Dr. Leight founded Leight Medical Communications, LLC in 2017, where she collaborates with teams of scientists and clinicians to clearly communicate their research findings to their intended audience. Dr. Leight’s passion for scientific research was kindled as an undergraduate intern while studying the mechanism of action of a viral oncogene. She earned her Ph.D. in Oncology from the University of Wisconsin-Madison McArdle Laboratory for Cancer Research studying the replication of a DNA tumor virus. She conducted her post-doctoral research at Washington University School of Medicine, where she utilized genetics, biochemistry and molecular biology to decipher the mechanism of action of a pivotal target of the Ras/MAPK signaling pathway that regulates cell proliferation. She served as a Senior Scientist studying the genomics and epigenomics of acute myeloid leukemia under the mentorship of Dr. Tim Ley, a pioneer in these fields. Dr. Leight authored Module 15: Latest Advances in Precision Medicine in Oncology.
Andrew McCarty, MS, CGC
Andrew McCarty, is a licensed and board-certified genetic counselor with a Master’s of Science in Genetic Counseling. He currently works at the Children’s Hospital of Pittsburgh as both a clinical and laboratory genetic counselor. He has authored modules 5 and 17. Andrew, earned his bachelor’s degree in microbiology from University of Pittsburgh in 2012. He then worked at Children’s in Pittsburgh for a year in the hematology and oncology unit assisting in cancer research efforts. He then moved to Philadelphia to work at CHOP participating in mitochondrial disease research efforts while completing his degree in genetic counseling at Arcadia University. He completed his master’s degree in early 2015. Later that year he began his current work at Children’s Hospital of Pittsburgh. Andrew, currently works with multiple clinics within Children’s through the Genetic Testing Clinic including the CF Center, Immunology, Neurogenetics, and Muscular Dystrophy among other clinics outside of Medical Genetics requiring genetic counseling. Additionally, Andrew spends some of his time in the laboratory department ensuring appropriate utilization and management of genetic testing sent from the hospital. Andrew belongs to the National Society of Genetic Counselor professional society and the Pennsylvania Association of Genetic Counselors. Andrew also participates in a multi-institutional effort called PLUGS (Pediatric Laboratory Utilization Guidance Services) to improve utilization of genetic testing both at local and more national levels.